Drug General Information
Drug ID
D04JTK
Former ID
DNC011499
Drug Name
(6-Benzylamino-9H-beta-carbolin-3-yl)-methanol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [533414]
Formula
C19H17N3O
Canonical SMILES
C1=CC=C(C=C1)CNC2=CC3=C(C=C2)NC4=CN=C(C=C34)CO
InChI
1S/C19H17N3O/c23-12-15-9-17-16-8-14(20-10-13-4-2-1-3-5-13)6-7-18(16)22-19(17)11-21-15/h1-9,11,20,22-23H,10,12H2
InChIKey
PCESGKMKSBKSOT-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Gamma-aminobutyric acid receptor subunit alpha-1 Target Info Inhibitor [533414]
Gamma-aminobutyric acid receptor Target Info Inhibitor [533414]
KEGG Pathway Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
GABAergic synapse
Morphine addiction
Nicotine addiction
Reactome Ligand-gated ion channel transport
GABA A receptor activation
WikiPathways SIDS Susceptibility Pathways
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
Iron uptake and transport
References
Ref 533414J Med Chem. 1987 Apr;30(4):750-3.Synthesis of 6-substituted beta-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists.
Ref 533414J Med Chem. 1987 Apr;30(4):750-3.Synthesis of 6-substituted beta-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists.